Page last updated: 2024-11-05

vigabatrin and Central Nervous System Diseases

vigabatrin has been researched along with Central Nervous System Diseases in 2 studies

Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.

Research Excerpts

ExcerptRelevanceReference
" An increase in the low frequency bands of the EEG and a decrease in the faster activity were correlated with the vigabatrin dosage injected."1.28The effect of vigabatrin on central nervous system oxygen toxicity in rats. ( Bitterman, N; Harel, D; Tzuk-Shina, T, 1991)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grove, J1
Tell, G1
Schechter, PJ1
Koch-Weser, J1
Warter, JM1
Marescaux, C1
Rumbach, L1
Tzuk-Shina, T1
Bitterman, N1
Harel, D1

Other Studies

2 other studies available for vigabatrin and Central Nervous System Diseases

ArticleYear
Increased CSF gamma-aminobutyric acid after treatment with gamma-vinyl GABA.
    Lancet (London, England), 1980, Sep-20, Volume: 2, Issue:8195 pt 1

    Topics: 4-Aminobutyrate Transaminase; Aminocaproates; Brain Chemistry; Central Nervous System Diseases; gamm

1980
The effect of vigabatrin on central nervous system oxygen toxicity in rats.
    European journal of pharmacology, 1991, Sep-17, Volume: 202, Issue:2

    Topics: Aminocaproates; Animals; Anticonvulsants; Central Nervous System Diseases; Dose-Response Relationshi

1991